Skip to main content
Glama

Cbioportal

by io.github.pipeworx-io

Send Pipeworx Feedback

pipeworx_feedback

Tell the Pipeworx team something is broken, missing, or needs to exist. Use when a tool returns wrong/stale data (bug), when a tool you wish existed isn't in the catalog (feature/data_gap), or when something worked surprisingly well (praise). ONLY for tools served by this Pipeworx connection — if the tool came from a different MCP server in your client (another vendor's Gmail, Splunk, Slack, etc. connector), we cannot fix it and reporting it here only delays you; file it with that server instead. Not sure? Pipeworx tool names are the ones this connection lists. Describe the issue in terms of Pipeworx tools/packs — don't paste the end-user's prompt. Filing without an account returns a claim_token; pass it back later as pipeworx_feedback({claim_token:"pwfb_…"}) to read whether it was fixed and what changed. The team reads digests daily and signal directly affects roadmap. Rate-limited to 5 per identifier per day. Free; doesn't count against your tool-call quota.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeNobug = something broke or returned wrong data. feature = a new tool or capability you wish existed. data_gap = data Pipeworx does not currently expose. praise = positive note. other = anything else.
contextNoOptional structured context: which tool, pack, or vertical this relates to.
messageNoYour feedback in plain text. Be specific (which tool, what error, what data was missing). 1-2 sentences typical, 2000 chars max.
claim_tokenNoRead the reply to a report you filed earlier: pass the `pwfb_…` token that filing returned, with no other arguments. Returns the status and, once resolved, what actually changed.

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations provide no useful signals (all false), so the description carries the full burden. It discloses rate limits (5/day), that filing returns a claim_token, that reads via token are possible, and that feedback is free and not quota-counting. These are genuine behavioral traits beyond schema.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

It is longer than most descriptions, but every sentence carries distinct, decision-relevant information. Front-loaded with purpose, then usage boundaries, then mechanics. Could be broken into bullets, but the density justifies the length for a tool with nuanced feedback routing.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (routing, claim tokens, rate limits) and weak annotations, this description covers all necessary context: what, when, when-not, how to follow up, and operational constraints. No output schema, but the token workflow is explained sufficiently.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with good per-parameter descriptions, but the description adds usage semantics beyond schema: claim_token must be passed alone, message should be 1-2 sentences, and context is optional. This enriches the bare parameter definitions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with a specific verb+resource: 'Tell the Pipeworx team something is broken, missing, or needs to exist.' It clearly distinguishes the tool from all siblings by focusing on feedback collection for this connection's tools, which no other sibling does.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly lists when to use (bug, feature/data_gap, praise) and gives a hard exclusion: 'if the tool came from a different MCP server... file it with that server instead.' Even clarifies ambiguous cases by referencing the connection's tool list. This is exemplary guidance.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Cbioportal toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation3/5

Most tools have clearly distinct purposes, but ask_pipeworx_beta is an intentional near-duplicate of ask_pipeworx, and several polymarket/entity tools overlap in scope. The descriptions do enough to disambiguate most pairs, but the duplicate beta routing tool introduces real ambiguity.

Naming Consistency3/5

All names use snake_case, but the pattern varies: verb_noun (get_gene, search_studies), noun_noun (polymarket_edges, pipeworx_trending), and product-prefixed verbs (ask_pipeworx, bet_research). There is no single consistent convention, though the names remain readable.

Tool Count2/5

35 tools is a heavy surface, and the vast majority (31) are unrelated to cBioPortal; only four tools actually belong to the named domain. This makes the count inappropriate for a cancer-genomics MCP server, as the set is bloated with out-of-scope utilities.

Completeness1/5

For a cBioPortal server, only metadata-level tools exist (gene lookup, study details, cancer types, study search); core cBioPortal data access — mutations, copy-number alterations, clinical data, molecular profiles, sample-level queries — is entirely missing. The tool surface severely under-covers the named domain.

Resources